New antibody drug shows promise in early cancer trial
NCT ID NCT06929195
First seen Apr 17, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This early-phase trial tested a new drug called TQB2210 in 16 people with advanced solid tumors. The drug is a lab-made antibody that targets a specific protein (FGFR2b) on cancer cells to block growth signals. The main goals were to find a safe dose and check for side effects, with a focus on stomach and gastroesophageal junction cancers that overexpress FGFR2b.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400030, China
-
Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)
Changsha, Hunan, 410005, China
-
Shanghai Tenth Hospital, Tongji University
Shanghai, Shanghai Municipality, 200032, China
-
The Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
-
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
ZhuJiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.